Back to Search Start Over

Characterizing the cellular and molecular variabilities of peripheral immune cells in healthy recipients of BBIBP-CorV inactivated SARS-CoV-2 vaccine by single-cell RNA sequencing

Authors :
Renyang Tong
Lingjie Luo
Yichao Zhao
Mingze Sun
Ronghong Li
Jianmei Zhong
Yifan Chen
Liuhua Hu
Zheng Li
Jianfeng Shi
Yuyan Lyu
Li Hu
Xiao Guo
Qi Liu
Tian Shuang
Chenjie Zhang
Ancai Yuan
Lingyue Sun
Zheng Zhang
Kun Qian
Lei Chen
Wei Lin
Alex F. Chen
Feng Wang
Jun Pu
Source :
Emerging Microbes and Infections, Vol 12, Iss 1 (2023)
Publication Year :
2023
Publisher :
Taylor & Francis Group, 2023.

Abstract

ABSTRACTOver 3 billion doses of inactivated vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been administered globally. However, our understanding of the immune cell functional transcription and T cell receptor (TCR)/B cell receptor (BCR) repertoire dynamics following inactivated SARS-CoV-2 vaccination remains poorly understood. Here, we performed single-cell RNA and TCR/BCR sequencing on peripheral blood mononuclear cells at four time points after immunization with the inactivated SARS-CoV-2 vaccine BBIBP-CorV. Our analysis revealed an enrichment of monocytes, central memory CD4+ T cells, type 2 helper T cells and memory B cells following vaccination. Single-cell TCR-seq and RNA-seq comminating analysis identified a clonal expansion of CD4+ T cells (but not CD8+ T cells) following a booster vaccination that corresponded to a decrease in the TCR diversity of central memory CD4+ T cells and type 2 helper T cells. Importantly, these TCR repertoire changes and CD4+ T cell differentiation were correlated with the biased VJ gene usage of BCR and the antibody-producing function of B cells post-vaccination. Finally, we compared the functional transcription and repertoire dynamics in immune cells elicited by vaccination and SARS-CoV-2 infection to explore the immune responses under different stimuli. Our data provide novel molecular and cellular evidence for the CD4+ T cell-dependent antibody response induced by inactivated vaccine BBIBP-CorV. This information is urgently needed to develop new prevention and control strategies for SARS-CoV-2 infection. (ClinicalTrials.gov Identifier: NCT04871932).

Details

Language :
English
ISSN :
22221751
Volume :
12
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Emerging Microbes and Infections
Publication Type :
Academic Journal
Accession number :
edsdoj.6942ea9b203e4df1a7d0d43f272ba194
Document Type :
article
Full Text :
https://doi.org/10.1080/22221751.2023.2187245